Complicated Appendicitis More Likely Among Patients With Psychiatric Disorders
Patients with acute appendicitis between 2000 and 2020 were evaluated for complications on the basis of having a mental health diagnosis.
Diagnosis & Disease Information
Lifestyle Modification Program Had Similar Outcomes as Mindfulness, Placebo in Treatment-Resistant Depression
A pragmatic, parallel-group, randomized control trial was conducted between 2020 and 2021 to ascertain whether a lifestyle modification program had an effect on patients with treatment-resistance depression.
5-ARIs Linked With Depression, But Not Suicide Risk
This Swedish population-based study has the largest sample size to date exploring these associations.
Interventions Targeting Repetitive Negative Thinking May Improve Depression, Anxiety
Can reducing RNT with psychological treatment approaches help improve youth depression and anxiety?
Vraylar Approved as Adjunctive Therapy for Major Depressive Disorder
The approval was based on data from 2 trials in adults who met DSM-IV-TR or DSM-5 criteria for MDD and had an inadequate response to 1 to 3 courses of prior antidepressant therapy.
Intranasal Therapy for Major Depressive Disorder Gets Fast Track Status
The designation is supported by data from 3 clinical studies.
Esketamine Nasal Spray Bests Quetiapine XR in Difficult-to-Treat Depression
The trial compared Spravato (esketamine nasal spray) to quetiapine extended-release, both in combination with a continuing SSRI or SNRI.
Smartphone Addiction: Tips for Assessment and Management
Determining when smartphone use has become an addiction in patients is tricky. Researchers outline what to look for.
Antidepressant Use in Pregnancy Underused: Provider and Patient Perspectives
Authors describe the perspectives of patients and prescribing clinicians regarding the use of antidepressants during pregnancy.
Auvelity Now Available for Major Depressive Disorder
The FDA approved Auvelity in August 2022 based on efficacy and safety data from the phase 3 GEMINI and phase 2 ASCEND trials.
- Loading...
Loading...
Next post in News
Loading... 
Loading...